Endocrinology, Vol 133, 1165-1172, Copyright © 1993 by Endocrine Society

ARTICLES

Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells

A Moldrup, ED Petersen and JH Nielsen
Hagedorn Research Institute, Gentofte, Denmark.

During pregnancy, marked hyperplasia of the pancreatic islet cells has been observed. This effect may be mediated by the pregnancy-associated peptide hormones, placental lactogen, PRL, and GH, which were previously shown to be mitogenic to beta-cells in vitro. To study whether the responsiveness of islet cells to these hormones is regulated on the receptor level, GH and PRL receptor gene expression was studied in pancreata from male rats and virgin, pregnant, and lactating female rats and in cultured islets and insulinoma cells (RIN- 5AH) in response to various hormones. The mRNA levels were quantitated by ribonuclease protection assay, using probes specific for mRNA encoding, extracellular and intracellular domains of the GH receptor, and short and long forms of the PRL receptor, respectively. Specific transcripts for the GH receptor were present in pancreas, islets, and RIN-5AH cells. Furthermore, as previously observed in RIN-5AH cells, a predominant expression of the long form of PRL receptor vs. the short form was also found in pancreas and islet cells. Male and nonpregnant female pancreas did not differ significantly in their levels of GH and PRL receptor mRNAs. On day 14 of pregnancy, increases in both GH and PRL receptor mRNA levels were observed (1.7- and 2.4-fold, respectively), and a further increase occurred in late pregnancy (day 19), when GH and PRL receptor mRNA levels were 2.7- and 3.9-fold higher than those in the nonpregnant state. mRNA levels returned toward the basal level during lactation. In the cultured islets, PRL receptor mRNA levels were markedly increased by GH and PRL (3.5- and 6.5-fold, respectively) after exposure for 24 h, whereas estradiol and testosterone had modest stimulating effects (1.8- and 1.5-fold increases, respectively). Dexamethasone induced a 2.5-fold increase in GH receptor mRNA levels, and a weak stimulatory effect was also observed for progesterone. In RIN-5AH cells, the effect of dexamethasone on GH receptor mRNA was detectable after 2 h and maximal after 16 h. In contrast, the effects of GH and PRL on PRL receptor mRNA required 24-48 h of exposure. The effective doses were within the physiological ranges. In conclusion, these results show a differential hormonal regulation of GH and PRL receptor gene expression in the pancreatic islets, which may play a role in the adaptive beta-cell growth during pregnancy.

This article has been cited by other articles:

				J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production J. Endocrinol., October 1, 2005; 187(1): 25 - 36. [Abstract] [Full Text] [PDF]

				J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607. [Abstract] [Full Text] [PDF]

				T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF]

				B. N. Friedrichsen, H. E. Richter, J. A. Hansen, C. J. Rhodes, J. H. Nielsen, N. Billestrup, and A. Moldrup Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells Mol. Endocrinol., May 1, 2003; 17(5): 945 - 958. [Abstract] [Full Text] [PDF]

				S. G. Ronn, J. A. Hansen, K. Lindberg, A. E. Karlsen, and N. Billestrup The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in {beta}-Cells Mol. Endocrinol., September 1, 2002; 16(9): 2124 - 2134. [Abstract] [Full Text] [PDF]

				T. C. Brelje, A. M. Svensson, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans J. Histochem. Cytochem., March 1, 2002; 50(3): 365 - 383. [Abstract] [Full Text] [PDF]

				I. Atwater, B. Gondos, R. DiBartolomeo, R. Bazaes, and L. Jovanovic Pregnancy Hormones Prevent Diabetes and Reduce Lymphocytic Infiltration of Islets in the NOD Mouse Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 87 - 92. [Abstract] [Full Text] [PDF]

				A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, September 26, 2001; (2001) 211445998. [Abstract] [Full Text] [PDF]

				A. K. Cardozo, M. Kruhøffer, R. Leeman, T. Ørntoft, and D. L. Eizirik Identification of Novel Cytokine-Induced Genes in Pancreatic {beta}-Cells by High-Density Oligonucleotide Arrays Diabetes, May 1, 2001; 50(5): 909 - 920. [Abstract] [Full Text]

				B. N. Friedrichsen, E. D. Galsgaard, J. H. Nielsen, and A. Møldrup Growth Hormone- and Prolactin-Induced Proliferation of Insulinoma Cells, INS-1, Depends on Activation of STAT5 (Signal Transducer and Activator of Transcription 5) Mol. Endocrinol., January 1, 2001; 15(1): 136 - 148. [Abstract] [Full Text]

				E. D. Galsgaard, J. H. Nielsen, and A. Moldrup Regulation of Prolactin Receptor (PRLR) Gene Expression in Insulin-producing Cells. PROLACTIN AND GROWTH HORMONE ACTIVATE ONE OF THE RAT PRLR GENE PROMOTERS VIA STAT5a AND STAT5b J. Biol. Chem., June 25, 1999; 274(26): 18686 - 18692. [Abstract] [Full Text] [PDF]

				L. E. Stout, A. M. Svensson, and R. L. Sorenson Prolactin Regulation of Islet-Derived INS-1 Cells: Characteristics and Immunocytochemical Analysis of STAT5 Translocation Endocrinology, April 1, 1997; 138(4): 1592 - 1603. [Abstract] [Full Text] [PDF]

				F. I. Sharara, D. Bhartiya, and L. K. Nieman Growth Hormone Receptor Gene Expression in the Mouse Uterus: Modulation by Gonadal Steroids Reproductive Sciences, October 1, 1994; 1(4): 285 - 289. [Abstract] [PDF]

				A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, October 9, 2001; 98(21): 12191 - 12196. [Abstract] [Full Text] [PDF]